Clozapine and associated diabetes mellitus

Journal of Clinical Psychiatry

Volumn 58, Issue 3, 1997, Pages 108-111

  Popli, Anand P ^a   Konicki, P Eric ^b   Jurjus, George J ^b   Fuller, Matthew A ^b   Jaskiw, George E ^b  

^a Porter Starke Counseling Centers   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOXAN; ASPARAGINASE; CHLORPROMAZINE; CLONIDINE; CLOZAPINE; CYCLOSPORIN A; DIAZOXIDE; ENCAINIDE; EPHEDRINE; GLIBENCLAMIDE; GLUCOSE; HALOPERIDOL; HEMOGLOBIN A1C; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; ISONIAZID; LISINOPRIL; LITHIUM; METHYLPHENIDATE; MORPHINE; MORPHINE SULFATE; MUDRANE; NALIDIXIC ACID; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PHENYTOIN; PROPRANOLOL; RIFAMPICIN; RISPERIDONE; SOMATOSTATIN; STREPTOZOCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ADULT; ARTICLE; CASE REPORT; DIABETES MELLITUS; DRUG INDUCED DISEASE; HUMAN; HYPERGLYCEMIA; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOIDISM; SCHIZOPHRENIA; WEIGHT GAIN;

EID: 0030931334     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v58n0304     Document Type: Article

References (14)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
2. Stanton JM. Weight gain associated with neuroleptic medication: a review. Schizophr Bull 1995;21:463-472
3. Leadbetter R, Shutty M, Pavalonis D, et al. Clozapine-induced weight gain: prevalence and clinical relevance. Am J Psychiatry 1992;149:68-72
4. Ghaeli P, Dufresne RL. Serum triglyceride levels in patients treated with Clozapine. Am J Health Syst Pharm 1996;53:2079-2081
5. Kamran A, Doraiswamy PM, Jane JL, et al. Severe hyperglycemia associated with high doses of clozapine [letter]. Am J Psychiatry 1994;151: 1395
6. Koval MS, Rames LJ, Christie S. Diabetic ketoacidosis with clozapine treatment [letter]. Am J Psychiatry 1994;151:1520-1521
7. Peterson GA, Byrd SL. Diabetic ketoacidosis from clozapine and lithium cotreatment. Am J Psychiatry 1996;153:737-738
8. Kostakoǧlu AE, Yazici KM, Erbas T, et al. Ketoacidosis as a side effect of clozapine: a case report. Acta Psychiatr Scand 1996;93:217-218
9. Lauter SA, Healy LA. Metropolitan height and weight tables. In: Viaz SL, ed. Practical Guide to Clinical Management. Philadelphia, Pa: Saunders; 1983
10. Ferner RE. Drug-induced diabetes. Baillière's Clinical Endocrinology and Metabolism 1992;6(4):849-865
11. Chan JCN, Cockram CS. Drug-induced disturbances of carbohydrate metabolism. Adverse Drug React Toxicol Rev 1991;10:1-29
12. National Diabetes Data Group. In: Diabetes in America. 2nd ed. Washington, DC: National Institute of Health, NIH publication no. 95-1468; 1995:51
13. Jubert P, Fernandez R, Ruiz A. Clozapine-related pancreatitis [letter]. Intern Med 1995;122(9):397
14. Martin A. Acute pancreatitis associated with clozapine use [letter]. Am J Psychiatry 1992;149:714